Journal of the American Chemical Society
Communication
bromoadamantane, and an acyclic tertiary iodide were not suitable
cross-coupling partners; (c) PhBpin, PhB(OH)2, and PhBF3K did not
afford significant amounts of coupling product (<5% yield).
(13) Several other meta-substituted aryl-(9-BBN) reagents, including
several halogenated compounds, were not effective coupling partners.
(14) Adapalene (Differin) is an example of a pharmaceutical that
includes a 1-aryladamantane.
(15) For a review of the use of the adamantyl group in medicinal
chemistry, see: Lamoureux, G.; Artavia, G. Curr. Med. Chem. 2010, 17,
2967.
Notes
The authors declare no competing financial interest.
ACKNOWLEDGMENTS
■
Support was provided by the National Institutes of Health
(National Institute of General Medical Sciences, R01-
GM62871) and Merck Research Laboratories (summer fellow-
ship for S.L.Z.). We thank Dr. Alexander S. Dudnik for
preliminary observations.
(16) Essentially no cross-coupling product was observed in the
absence of NiBr2·diglyme.
(17) For two recent advances and leading references, see: (a) Joshi-
Pangu, A.; Wang, C.-Y.; Biscoe, M. R. J. Am. Chem. Soc. 2011, 133,
REFERENCES
■
(1) For reviews and leading references, see: (a) Glasspoole, B. W.;
Crudden, C. M. Nat. Chem. 2011, 3, 912. (b) Glorius, F. Angew. Chem.,
Int. Ed. 2008, 47, 8347. (c) Rudolph, A.; Lautens, M. Angew. Chem.,
Int. Ed. 2009, 48, 2656. (d) Terao, J.; Kambe, N. Acc. Chem. Res. 2008,
41, 1545. (e) Hu, X. Chimia 2010, 64, 231.
8478. (b) Lohre, C.; Droge, T.; Wang, C.; Glorius, F. Chem.Eur. J.
̈
2011, 17, 6052.
(2) For a recent application of an asymmetric Negishi cross-coupling
of an alkyl electrophile in a total synthesis of carolacton, see: Schmidt,
T.; Kirschning, A. Angew. Chem., Int. Ed. 2012, 51, 1063.
(3) For examples of cross-couplings (not Heck reactions or other
related processes) that provide >50% yield with an unactivated tertiary
alkyl halide other than a 1-haloadamantane (which cannot eliminate
HX), see: (a) Allylmagnesium (Co): Tsuji, T.; Yorimitsu, H.; Oshima,
K. Angew. Chem., Int. Ed. 2002, 41, 4137. Ohmiya, H.; Tsuji, T.;
Yorimitsu, H.; Oshima, K. Chem.Eur. J. 2004, 10, 5640. (b) Allyl-
and benzylmagnesium (Ag): Someya, H.; Ohmiya, H.; Yorimitsu, H.;
Oshima, K. Org. Lett. 2008, 10, 969. Mitamura, Y.; Someya, H.;
Yorimitsu, H.; Oshima, K. Synlett 2010, 309. (c) Cyclopentadie-
nylmagnesium (Cu): Sai, M.; Someya, H.; Yorimitsu, H.; Oshima, K.
Org. Lett. 2008, 10, 2545. (d) Allylmagnesium (Cu): Sai, M.;
Yorimitsu, H.; Oshima, K. Bull. Chem. Soc. Jpn. 2009, 82, 1194. (e)
Allyl- and benzylzinc (Ag): Mitamura, Y.; Asada, Y.; Murakami, K.;
Someya, H.; Yorimitsu, H.; Oshima, K. Chem.Asian J. 2010, 5, 1487.
(f) Indenyllithium (Ag): Someya, H.; Yorimitsu, H.; Oshima, K.
Tetrahedron 2010, 66, 5993.
(4) For leading references to mechanistic studies of Ni-catalyzed
Suzuki reactions of unactivated alkyl electrophiles, see: Wilsily, A.;
Tramutola, F.; Owston, N. A.; Fu, G. C. J. Am. Chem. Soc. 2012, 134,
5794.
(5) For early mechanistic studies of Ni-catalyzed Negishi reactions of
unactivated alkyl electrophiles, see: (a) Jones, G. D.; Martin, J. L.;
McFarland, C.; Allen, O. R.; Hall, R. E.; Haley, A. D.; Brandon, R. J.;
Konovalova, T.; Desrochers, P. J.; Pulay, P.; Vicic, D. A. J. Am. Chem.
Soc. 2006, 128, 13175. (b) Phapale, V. B.; Bunuel, E.; García-Iglesias,
̃
́
M.; Cardenas, D. J. Angew. Chem., Int. Ed. 2007, 46, 8790. (c) Lin, X.;
Phillips, D. L. J. Org. Chem. 2008, 73, 3680.
(6) For discussions and leading references, see: (a) Hu, X. Chem. Sci.
2011, 2, 1867. (b) Phapale, V. B.; Cardenas, D. J. Chem. Soc. Rev.
2009, 38, 1598.
(7) Dudnik, A. S.; Fu, G. C. J. Am. Chem. Soc. 2012, 134, 10693.
(8) For leading references, see: (a) Suzuki, A. Angew. Chem., Int. Ed.
2011, 50, 6722. (b) Metal-Catalyzed Cross-Coupling Reactions; de
Meijere, A., Diederich, F., Eds.; Wiley-VCH: New York, 2004.
(c) Handbook of Organopalladium Chemistry for Organic Synthesis;
Negishi, E.-i., Ed.; Wiley Interscience: New York, 2002.
(9) For recent examples and leading references, see ref 4 and:
Zultanski, S. L.; Fu, G. C. J. Am. Chem. Soc. 2011, 133, 15362.
(10) (a) Ligand = 3: Zhou, J.; Fu, G. C. J. Am. Chem. Soc. 2004, 126,
1340 (footnote 15: “Under our standard conditions, primary and
tertiary alkyl bromides...are not suitable substrates.”). (b) Ligand =
amino alcohol: Gonzal
128, 5360.
́
ez-Bobes, F.; Fu, G. C. J. Am. Chem. Soc. 2006,
(11) For leading references, see: James, K. S.; Colette, R.; Forbes, K.;
Hanks, G. Palliative Med. 2011, 25, 454.
(12) Under our standard conditions: (a) when the cross-coupling
illustrated in entry 1 of Table 2 was conducted in a capped vial under
an atmosphere of air, the desired product was generated in 31% yield;
(b) an unactivated primary or secondary alkyl bromide/iodide, 1-
D
dx.doi.org/10.1021/ja311669p | J. Am. Chem. Soc. XXXX, XXX, XXX−XXX